protein kinase c pkc inhibition a promise not yet
play

Protein Kinase C- ( PKC- ) Inhibition: A Promise not yet Fulfilled - PowerPoint PPT Presentation

Sep 29, 2023 •279 likes •415 views

Protein Kinase C- ( PKC- ) Inhibition: A Promise not yet Fulfilled Ruboxistaurin, an oral PKC- , was withdrawn on March 15, 2007 by Eli Lilly Dual Inhibition of Classical Protein Kinase C- and Protein Kinase C- Isoforms Protects

  1. Protein Kinase C- β ( PKC- β ) Inhibition: A Promise not yet Fulfilled Ruboxistaurin, an oral PKC- β, was withdrawn on March 15, 2007 by Eli Lilly

  2. Dual Inhibition of Classical Protein Kinase C- α and Protein Kinase C- β Isoforms Protects Against Diabetic Nephropathy Diabetes 2013;62:1010-1011

  3. ASCEND Trial: Endothelin Receptor Antagonist Avosentan Significantly Decreased Albuminuria Terminated due to increased CHF and deaths J Am Soc Nephrol 2010;21:527–535

  4. Addition of Atrasentan, an Endothelin Receptor Antagonist, to RAS Blockade Reduces Albuminuria in Diabetic Nephropathy Baseline UACR ~400 mg/g CR J Am Soc Nephrol 2011;22:763-772

  5. Atrasentan Restores Endothelial Glycocalyx Thickness Diabetes 2016;65:2429-2439

  6. Pirfenidone, an Inhibitor of TGF- β at 1200 mg/d, but NOT 2400 mg/d, Improves eGFR from Baseline Pirfenidone (Esbriet) approved to treat idiopathic pulmonary fibrosis J Am Soc Nephrol 2011;22:1144–1151

  7. Pentoxifylline-Lower Decline in eGFR and Greater UAE Reduction Baseline UAE ~1000 mg/day J Am Soc Nephrol 2015;26:220–229

  8. CCX140-B (CCR2 Antagonist) Lowers Albuminuria in Patients with Type 2 DM Monocyte chemoattractant protein-1 (MCP-1), also called C-C chemokine receptor 2 (CCR2) Baseline UAE 400 mg/day Lancet Diabetes & Endo 2015;3:687-696

  9. Pyridoxamine (Pyridorin), a Derivative of Vitamin B6, Inhibits the Formation of Advanced Glycation Endproducts I.V. form of Pyridorin for use in hospital-acquired acute kidney injury Nephron 2015;129:22–28

  10. Finerenone, a 3 rd Generation Nonsteroidal Mineralocorticoid Receptor Antagonists Lowers Albuminuria Baseline UACR ~200 mg/g CR JAMA 2015;314:884-894

  11. Patiromer (Veltassa)— Twice Daily Lowered Potassium Levels FDA Approved on October 22, 2015 but with a Black Box Warning N Engl J Med 2015;372:211-221

  12. Sodium Zirconium Cyclosilicate (ZS-9) 3X Daily X2 days ↓ Hyperkalemia AstraZeneca receives Complete Response Letter from FDA May 27, 2016 JAMA 2014;312:2223-2233

  13. Metformin Improves Whole-Body Glycocalyx Barrier Properties Cardiovasc Diabetol 2013;12:175

Recommend

Inhibition of Fyn Kinase for Disease- Modifying Therapy of Alzheimers Disease Stephen M.

Inhibition of Fyn Kinase for Disease- Modifying Therapy of Alzheimers Disease Stephen M.

Inhibition of Fyn Kinase for Disease- Modifying Therapy of Alzheimers Disease Stephen M. Strittmatter, M.D., Ph.D. Vince Coates Professor Neurology Director, Cellular Neuroscience, Neurodegeneration & Repair Director, Memory Disorders

784 views • 55 slides
Abietane Diterpenoids from Plectranthus spp. as a potential new class of Protein Kinase C

Abietane Diterpenoids from Plectranthus spp. as a potential new class of Protein Kinase C

Abietane Diterpenoids from Plectranthus spp. as a potential new class of Protein Kinase C Modulators Patrcia Rijo 1,2* , Vera M. S. Isca 1,2 , Epole Ntungwe 1 , Cludia Bessa 3 , Carlos A.M. Afonso 2 , Luclia Saraiva 3 1 Center for Research in

538 views • 22 slides
New Insights into Covalent Enzyme Inhibition Application to Anti-Cancer Drug Design Petr Kuzmi

New Insights into Covalent Enzyme Inhibition Application to Anti-Cancer Drug Design Petr Kuzmi

New Insights into Covalent Enzyme Inhibition Application to Anti-Cancer Drug Design Petr Kuzmi , Ph.D. BioKin, Ltd. December 5, 2014 Brandeis University Synopsis For a particular group of covalent (irreversible) protein kinase inhibitors:

627 views • 25 slides
Progress on the co-crystallization of Thermoplasma acidophilum nucleoside kinase (TaNK) with

Progress on the co-crystallization of Thermoplasma acidophilum nucleoside kinase (TaNK) with

Progress on the co-crystallization of Thermoplasma acidophilum nucleoside kinase (TaNK) with substrates Jessica Yoo Columbus Lab CSS Symposium 1 Protein Misannotation High as for some protein families 1 80% Accuracy

170 views • 12 slides
human protein kinase CK2 Christian Nienberg 1, *, Anika Retterath 1 , Kira Sophie Becher 2 ,

human protein kinase CK2 Christian Nienberg 1, *, Anika Retterath 1 , Kira Sophie Becher 2 ,

Click chemistry for advanced drug discovery applications of human protein kinase CK2 Christian Nienberg 1, *, Anika Retterath 1 , Kira Sophie Becher 2 , Henning D. Mootz 2 and Joachim Jose 1 1 Institut fr Pharmazeutische und Medizinische Chemie,

619 views • 15 slides
Prediction of Human Protein Kinase Substrate Specificities Javad Safaei 1 , Jan Manuch 1 , Arvind

Prediction of Human Protein Kinase Substrate Specificities Javad Safaei 1 , Jan Manuch 1 , Arvind

Prediction of Human Protein Kinase Substrate Specificities Javad Safaei 1 , Jan Manuch 1 , Arvind Gupta 1 , Ladislav Stacho 2 , Steven Pelech 3 1. UBC, Department of Computer Science 2. SFU, Department of Mathematics 3. UBC, Department of

497 views • 17 slides
PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE What is Pierce

PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE What is Pierce

Pierce College Promise PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE PIERCE PROMISE What is Pierce Promise? The Pierce Promise provides one year of free tuition to all full-time students graduating from your high

301 views • 19 slides
Elucidating cell-to-cell variability in phosphorylation of the ERK MAP kinase Sarah Filippi

Elucidating cell-to-cell variability in phosphorylation of the ERK MAP kinase Sarah Filippi

Elucidating cell-to-cell variability in phosphorylation of the ERK MAP kinase Sarah Filippi Imperial College London Theoretical Systems Biology Group 20/02/2013 The ERK MAP pathway In eukaryotes Mitogen-activated protein (MAP) kinases

411 views • 29 slides
1 Excitatory Inhibitory excitation inhibition 2 excitation excitation inhibition

1 Excitatory Inhibitory excitation inhibition 2 excitation excitation inhibition

1 Excitatory Inhibitory excitation inhibition 2 excitation excitation inhibition inhibition Synaptic strength (receptors, transporters, Metabolic changes transmitter release, etc.) (anoxia, hypoglycemia) Membrane properties Cell

264 views • 9 slides
Protein Kinase C Modulates Wnt Signaling In Colon Tumoral Cell Lines Dra Martha Robles Flores

Protein Kinase C Modulates Wnt Signaling In Colon Tumoral Cell Lines Dra Martha Robles Flores

Protein Kinase C Modulates Wnt Signaling In Colon Tumoral Cell Lines Dra Martha Robles Flores Dra Martha Robles Flores Department of Biochemistry Department of Biochemistry Facultad de Medicina Facultad de Medicina Universidad Nacional

608 views • 18 slides
Design and Development of 9,10-Dihydrophenanthrene Derivatives as Inhibitors of Human Protein

Design and Development of 9,10-Dihydrophenanthrene Derivatives as Inhibitors of Human Protein

Design and Development of 9,10-Dihydrophenanthrene Derivatives as Inhibitors of Human Protein Kinase CK2 S. Haidar, A. Meyers, and J. Jose 1 Institut fr Pharmazeutische und Medizinische Chemie, PharmaCampus, Westflische Wilhelms-Universitt

627 views • 15 slides
A Comparison of Angiotensin Receptor- Neprilysin Inhibition (ARNI) With ACE Inhibition in the

A Comparison of Angiotensin Receptor- Neprilysin Inhibition (ARNI) With ACE Inhibition in the

A Comparison of Angiotensin Receptor- Neprilysin Inhibition (ARNI) With ACE Inhibition in the Long-Term Treatment of Chronic Heart Failure With a Reduced Ejection Fraction Milton Packer, John J.V. McMurray, Akshay S. Desai, Jianjian Gong,

599 views • 32 slides
IMPROVED STUDIES ON MALIGNANCIES WITH A NOVEL PROLIFERATION BIOMARKER - Thymidine Kinase 1

IMPROVED STUDIES ON MALIGNANCIES WITH A NOVEL PROLIFERATION BIOMARKER - Thymidine Kinase 1

IMPROVED STUDIES ON MALIGNANCIES WITH A NOVEL PROLIFERATION BIOMARKER - Thymidine Kinase 1 AROCELL TK 210 ELISA 1 AGENDA 1 Proliferation Biomarkers 2 Thymidine Kinase 1 as a Tumor Biomarker 3 Thymidine Kinase 1 in the Study of Hematological

500 views • 37 slides
Addressing Key Mechanisms of Tumor Drug Resistance July 2018 Kinase switch control inhibitors

Addressing Key Mechanisms of Tumor Drug Resistance July 2018 Kinase switch control inhibitors

Addressing Key Mechanisms of Tumor Drug Resistance July 2018 Kinase switch control inhibitors for tumor- targeted and immune-targeted cancer therapies Our Proprietary Kinase Switch Control Platform Kinase Switched Off Kinase Switched

401 views • 16 slides
Unusual binding modes of two inhibitors to their target enzymes human leukocyte elastase (HLE) and

Unusual binding modes of two inhibitors to their target enzymes human leukocyte elastase (HLE) and

Unusual binding modes of two inhibitors to their target enzymes human leukocyte elastase (HLE) and protein kinase CK2 revealed by protein crystallography Jennifer Hochscherf and Karsten Niefind* University of Cologne, Institute of Biochemistry,

383 views • 23 slides
1 Non-competitive inhibition - A possible mechanism Non-competitive inhibition - Kinetics

1 Non-competitive inhibition - A possible mechanism Non-competitive inhibition - Kinetics

Anthrax bacillus CUTANEOUS AND INHALATION ANTHRAX DISEASE ier Bio/ Chem ical Kinetics Made Easy A Numerical Approach Petr Kuzmi , Ph.D. BioKin, Ltd. 1. Case study: Inhibition of LF protease from B. a nthracis 2. Method: Num erical Enzym e

112 views • 8 slides
Synthesis and Anticancer Activity of Novel Bisindolylhydroxymaleimide Derivatives with Potent

Synthesis and Anticancer Activity of Novel Bisindolylhydroxymaleimide Derivatives with Potent

Synthesis and Anticancer Activity of Novel Bisindolylhydroxymaleimide Derivatives with Potent GSK-3 Kinase Inhibition Kevin D. OShea 1 , Hannah J. Winfield 1 and Michael M. Cahill 1 , Dr. Florence O. McCarthy 1,* 1 School of Chemistry and

423 views • 27 slides
1 EGFR inhibition by covalent drugs Schwartz, P.; Kuzmic, P. et al . (2014) Covalent EGFR

1 EGFR inhibition by covalent drugs Schwartz, P.; Kuzmic, P. et al . (2014) Covalent EGFR

Irreversible Inhibition Kinetics Automation and Simulation Petr Kuzmi , Ph.D. BioKin, Ltd. 1. Automate the determination of biochemical parameters 2. PK/PD simulations with multiple injections Irreversible Inhibition Kinetics 1

430 views • 13 slides
Limulus in light to voltage transduction and adaptation voltage to spike encoding rate 3

Limulus in light to voltage transduction and adaptation voltage to spike encoding rate 3

9/23/2011 Crab cam (Barlow et al., 2001) self inhibition recurrent inhibition lateral inhibition - L17. Neural processing in Linear Systems 2: Spatial Filtering C. D. Hopkins Sept. 23, 2011 Limulus eye: a filter cascade. Limulus in light

410 views • 10 slides
Protein-Protein interactions Reducing the complexity Why are protein-protein interactions

Protein-Protein interactions Reducing the complexity Why are protein-protein interactions

12/3/2012 Protein-Protein interactions Reducing the complexity Why are protein-protein interactions important? Identify proteins in complexes. Identify proteins that are in a metabolic or signaling pathway. Identify members of a

816 views • 8 slides
PROMISE INDIANA Technical Aspects How Promise Works February 23, 2017 HOW PROMISE WORKS

PROMISE INDIANA Technical Aspects How Promise Works February 23, 2017 HOW PROMISE WORKS

PROMISE INDIANA Technical Aspects How Promise Works February 23, 2017 HOW PROMISE WORKS Community Coalition Building Community Application Process Support for Promise Communities Technical Aspects and Innovation

304 views • 12 slides
Living the Promise: Living the Promise: Building the Future Building the Future Dale Braun

Living the Promise: Living the Promise: Building the Future Building the Future Dale Braun

Living the Promise: Living the Promise: Building the Future Building the Future Dale Braun Gregg Heinselman Nancy Devine Campus Planner Assoc. Vice Chancellor President UWRF Foundation Living the Promise: Living the Promise: Building

1.02k views • 64 slides
Driver Kinase Fusions in Cancer TCGA 4 th Annual Scientific Symposium May 12 th , 2015 Nicolas

Driver Kinase Fusions in Cancer TCGA 4 th Annual Scientific Symposium May 12 th , 2015 Nicolas

Driver Kinase Fusions in Cancer TCGA 4 th Annual Scientific Symposium May 12 th , 2015 Nicolas Stransky, PhD What are Kinase Fusions? KIF5B-RET Fusion Genomic instability, a hallmark of cancer, can result in chromosomal translocations or

212 views • 17 slides
DNA RNA Protein synthesis AMINO ACIDS PROTEIN Protein degradation FUNCTION Some properties

DNA RNA Protein synthesis AMINO ACIDS PROTEIN Protein degradation FUNCTION Some properties

DNA RNA Protein synthesis AMINO ACIDS PROTEIN Protein degradation FUNCTION Some properties of intracellular protein degradation (1970). Abnormal proteins are rapidly eliminated. Normal proteins are selectively degraded at widely

866 views • 29 slides

More recommend